AMN Healthcare Services (NYSE:AMN) Stock Price Up 16.5% Following Strong Earnings

Key Points

• AMN Healthcare’s shares jumped 16.5% after the company reported adjusted EPS of $0.77, far exceeding the $0.19 consensus estimate. Quarterly revenue rose 2.3% year over year to $673.2 million, also beating expectations.
• Management forecast third-quarter revenue of $640 million to $655 million, above analysts’ estimate of roughly $618 million, indicating stronger near-term expectations.
• Despite the earnings beat, AMN’s GAAP net margin remained negative at 0.95%, and analysts’ consensus rating is still “Hold” with a $29 price target, below the recent share price.

AMN Healthcare Services Inc (NYSE:AMN - Get Free Report)'s share price traded up 16.5% during trading on Friday following a better than expected earnings announcement. The stock traded as high as $35.27 and last traded at $35.89. Approximately 186,304 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 1,133,735 shares. The stock had previously closed at $30.80.

The company reported $0.77 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.19 by $0.58. AMN Healthcare Services had a positive return on equity of 18.01% and a negative net margin of 0.95%.The company had revenue of $673.24 million for the quarter, compared to analyst estimates of $628.39 million. During the same quarter in the previous year, the company earned $0.30 earnings per share. The firm's quarterly revenue was up 2.3% compared to the same quarter last year.

AMN Healthcare Services News Summary

Here are the key news stories impacting AMN Healthcare Services this week:

• Positive Sentiment: AMN reported second-quarter adjusted EPS of $0.77, well above the $0.19–$0.22 analyst estimates and up from $0.30 in the year-ago quarter. Revenue rose 2.3% year over year to $673 million, exceeding consensus near $628 million. Adjusted EBITDA was $73 million, while GAAP EPS was $0.53. AMN Healthcare Announces Second Quarter 2026 Results
• Positive Sentiment: Management’s third-quarter revenue outlook of $640 million to $655 million is above the roughly $618 million consensus estimate, suggesting continued operating momentum and better near-term visibility. AMN Healthcare Q2 Earnings and Revenues Beat Estimates
• Neutral Sentiment: The earnings call and results coverage highlighted the quarterly beat and management’s outlook. Investors are likely focused on whether the improved profitability can persist and translate into stronger growth across AMN’s healthcare staffing and talent-solutions businesses. AMN Healthcare Q2 2026 Earnings Call Transcript
• Negative Sentiment: Despite the adjusted earnings beat, GAAP net margin remained negative at 0.95%, and revenue growth was relatively modest. The stock’s weaker reaction likely reflects profit-taking or concern that the headline earnings strength may not yet represent a broad, durable acceleration in demand. AMN Healthcare Q2 Earnings Key Metrics

Wall Street Analyst Weigh In

AMN has been the subject of several recent research reports. Wall Street Zen lowered shares of AMN Healthcare Services from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 1st. Truist Financial increased their price objective on AMN Healthcare Services from $26.00 to $40.00 and gave the company a "buy" rating in a research note on Wednesday, July 22nd. BMO Capital Markets upped their price target on AMN Healthcare Services from $25.00 to $26.00 and gave the stock an "outperform" rating in a report on Monday, May 11th. Citizens Jmp reiterated a "market outperform" rating and issued a $36.00 price objective on shares of AMN Healthcare Services in a research note on Tuesday, June 23rd. Finally, Citigroup reaffirmed a "market outperform" rating on shares of AMN Healthcare Services in a report on Tuesday, June 23rd. Four equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, AMN Healthcare Services presently has an average rating of "Hold" and a consensus price target of $29.00.

Insider Buying and Selling at AMN Healthcare Services

In other news, Director Mark G. Foletta sold 3,681 shares of the company's stock in a transaction on Monday, June 15th. The shares were sold at an average price of $31.07, for a total value of $114,368.67. Following the completion of the transaction, the director owned 17,917 shares in the company, valued at approximately $556,681.19. This represents a 17.04% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.07% of the company's stock.

Hedge Funds Weigh In On AMN Healthcare Services

Several large investors have recently bought and sold shares of the stock. Millennium Management LLC increased its position in shares of AMN Healthcare Services by 55.8% during the fourth quarter. Millennium Management LLC now owns 2,005,966 shares of the company's stock worth $31,614,000 after purchasing an additional 718,048 shares in the last quarter. State Street Corp increased its position in AMN Healthcare Services by 1.8% during the fourth quarter. State Street Corp now owns 1,624,935 shares of the company's stock worth $25,609,000 after buying an additional 28,479 shares during the period. Arrowstreet Capital Limited Partnership lifted its stake in AMN Healthcare Services by 1,278.0% in the first quarter. Arrowstreet Capital Limited Partnership now owns 1,401,725 shares of the company's stock valued at $25,708,000 after buying an additional 1,300,005 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in shares of AMN Healthcare Services by 50.7% in the first quarter. Renaissance Technologies LLC now owns 1,376,341 shares of the company's stock valued at $25,242,000 after acquiring an additional 463,100 shares during the period. Finally, Boston Partners grew its position in shares of AMN Healthcare Services by 7,583.1% during the fourth quarter. Boston Partners now owns 1,035,145 shares of the company's stock worth $16,313,000 after acquiring an additional 1,021,672 shares during the last quarter. Institutional investors and hedge funds own 99.23% of the company's stock.

AMN Healthcare Services Stock Up 16.2%

The firm has a market capitalization of $1.39 billion, a price-to-earnings ratio of -41.23, a PEG ratio of 0.75 and a beta of 0.40. The business's fifty day moving average price is $32.37 and its 200 day moving average price is $25.01. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 1.04.

About AMN Healthcare Services

AMN Healthcare Services, Inc NYSE: AMN is a leading provider of healthcare workforce solutions in the United States. The company specializes in staffing and recruitment services for a broad range of clinical and allied health professionals, including travel nurses, permanent placement of nursing staff, locum tenens physicians, and allied health personnel. In addition to direct staffing, AMN Healthcare offers comprehensive workforce management solutions such as vendor management systems (VMS), recruitment process outsourcing (RPO), and compliance and credentialing services through its technology platforms.

Founded in 1985 as American Mobile Nurses, the company rebranded to AMN Healthcare in 2010 to reflect its expanding portfolio of services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source